Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New York, NY–(Newsfile Corp. – Dec 12, 2024) – Law Firm Kirby (NISE:) McInerney LLP is investigating potential claims against Applied Therapeutics (NASDAQ:), Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT). The investigation concerns whether Applied Therapeutics and/or certain of its officers violated federal securities laws and/or engaged in other illegal business practices.
(Click here to learn more about the investigation)
On November 27, 2024, Applied Therapeutics disclosed that it received a Complete Response Letter (“CRL”) from the US Food and Drug Administration (“FDA”) regarding a New Drug Application (“NDA”) for a classic drug for company’s galactosemia , goverostat, stating that “
If you have purchased or otherwise acquired securities of Applied Therapeutics, have information or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investments@kmllp.com, or by completing this CONTACT FORM, to discuss your rights or interests in these matters at no cost to you.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm that practices securities, antitrust, whistleblower and consumer litigation. The company’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
This press release may be considered solicitor advertising in some jurisdictions under applicable law and ethics rules.
To view the original version of this press release, visit https://www.nevsfilecorp.com/release/233530
